CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-274224 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
120,000
Total Value
$4,016,300.05
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 40,000 | $19.26 | $770,400.00 | 56,130 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 15, 2026 | Sale | 9,434 | $80.02 | $754,923.77 | 46,696 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 15, 2026 | Sale | 11,081 | $80.94 | $896,922.73 | 35,615 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 15, 2026 | Sale | 19,483 | $81.81 | $1,593,888.64 | 16,132 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 15, 2026 | Sale | 2 | $82.45 | $164.90 | 16,130 | Direct | โ | View Details | |
Chief Financial Officer | Stock option (right to buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 40,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |